TABLE 1.
Serum no. | Titer of NAa with indicated cell type
|
||||||
---|---|---|---|---|---|---|---|
None | MBM | PBMC | PLB-d3 | PLB-d12 | CrFK | KB | |
Vaccinated | |||||||
727 | <16 | 512 | <16 | <16 | 64 | 512 | 16 |
733 | <16 | 512 | <16 | <16 | 128 | 64 | <16 |
737 | <16 | 512 | <16 | <16 | 64 | 32 | <16 |
3607 | <16 | 512 | <16 | <16 | 128 | 512 | 16 |
Infectedb | |||||||
753 | 256 | 512 | NDc | ND | ND | ND | ND |
792 | 512 | 512 | ND | ND | ND | ND | ND |
3573 | 256 | 512 | ND | ND | ND | ND | ND |
3588 | 512 | 512 | ND | ND | ND | ND | ND |
3603 | 512 | 512 | ND | ND | ND | ND | ND |
Uninfected, unvaccinated (6 sera) | <16 | <16 | ND | ND | ND | ND | ND |
The titer is expressed as the reciprocal of the highest serum dilution that gave 50% inhibition of reverse transcriptase production by 10 50% tissue culture infectious doses of FIV-M2 mixed with the corresponding dilution of a pool of 10 normal cat sera and calculated by the Reed and Müench method (28). The experiment was repeated twice, with comparable results.
These cats were infected with plasma from FIV-M2-infected cats; sera were obtained 1 year later.
ND, not done.